Obesity and cancer: mechanistic insights from transdisciplinary studies

EH Allott, SD Hursting - Endocrine-related cancer, 2015‏ - erc.bioscientifica.com
Obesity is associated with a range of health outcomes that are of clinical and public health
significance, including cancer. Herein, we summarize epidemiologic and preclinical …

Concise review: prostate cancer stem cells: current understanding

S Skvortsov, II Skvortsova, DG Tang, A Dubrovska - Stem Cells, 2018‏ - academic.oup.com
Prostate cancer (PCa) is heterogeneous, harboring phenotypically diverse cancer cell types.
PCa cell heterogeneity is caused by genomic instability that leads to the clonal competition …

[HTML][HTML] Combination of hypoglycemia and metformin impairs tumor metabolic plasticity and growth by modulating the PP2A-GSK3β-MCL-1 axis

M Elgendy, M Ciro, A Hosseini, J Weiszmann… - Cancer cell, 2019‏ - cell.com
Tumor cells may adapt to metabolic challenges by alternating between glycolysis and
oxidative phosphorylation (OXPHOS). To target this metabolic plasticity, we combined …

[HTML][HTML] GLS-driven glutamine catabolism contributes to prostate cancer radiosensitivity by regulating the redox state, stemness and ATG5-mediated autophagy

A Mukha, U Kahya, A Linge, O Chen, S Löck… - Theranostics, 2021‏ - ncbi.nlm.nih.gov
Radiotherapy is one of the curative treatment options for localized prostate cancer (PCa).
The curative potential of radiotherapy is mediated by irradiation-induced oxidative stress …

Regulation of tumor cell migration and invasion by the H19/let-7 axis is antagonized by metformin-induced DNA methylation

L Yan, J Zhou, Y Gao, S Ghazal, L Lu, S Bellone… - Oncogene, 2015‏ - nature.com
The imprinted, developmentally regulated H19 long noncoding RNA has been implicated in
the pathogenesis of diverse human cancers, but the underlying mechanisms have remained …

Metformin use and prostate cancer risk

MA Preston, AH Riis, V Ehrenstein, RH Breau… - European urology, 2014‏ - Elsevier
Background Metformin may decrease prostate cancer (PCa) risk by reducing
hyperinsulinemia-associated carcinogenesis or through direct effects on cancer cells …

Paradoxic effects of metformin on endothelial cells and angiogenesis

K Dallaglio, A Bruno, AR Cantelmo, AI Esposito… - …, 2014‏ - academic.oup.com
The biguanide metformin is used in type 2 diabetes management and has gained significant
attention as a potential cancer preventive agent. Angioprevention represents a mechanism …

Effects of metformin and phenformin on apoptosis and epithelial‐mesenchymal transition in chemoresistant rectal cancer

JH Park, Y Kim, EH Park, SJ Lee, H Kim, A Kim… - Cancer …, 2019‏ - Wiley Online Library
Recurrence and chemoresistance in colorectal cancer remain important issues for patients
treated with conventional therapeutics. Metformin and phenformin, previously used in the …

Regulation and role of CAMKK2 in prostate cancer

TL Pulliam, P Goli, D Awad, C Lin… - Nature Reviews …, 2022‏ - nature.com
Abstract In 2011, CAMKK2, the gene encoding calcium/calmodulin-dependent kinase
kinase 2 (CAMKK2), was demonstrated to be a direct target of the androgen receptor and a …

[HTML][HTML] Metformin repositioning as antitumoral agent: selective antiproliferative effects in human glioblastoma stem cells, via inhibition of CLIC1-mediated ion current

M Gritti, R Würth, M Angelini, F Barbieri, M Peretti… - Oncotarget, 2014‏ - ncbi.nlm.nih.gov
Metformin repositioning as antitumoral agent: selective antiproliferative effects in human
glioblastoma stem cells, via inhibition of CLIC1-mediated ion current - PMC Back to Top Skip to …